Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer. (2022). Cermin Dunia Kedokteran, 49(12), 693-701. https://doi.org/10.55175/cdk.v49i12.329